GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Cell Impact (OSTO:CI) » Definitions » Cash And Cash Equivalents

Cell Impact (OSTO:CI) Cash And Cash Equivalents : kr47.62 Mil (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Cell Impact Cash And Cash Equivalents?

Cell Impact's quarterly cash and cash equivalents increased from Sep. 2023 (kr35.09 Mil) to Dec. 2023 (kr99.89 Mil) but then stayed the same from Dec. 2023 (kr99.89 Mil) to Mar. 2024 (kr47.62 Mil).

Cell Impact's annual cash and cash equivalents increased from Dec. 2021 (kr28.56 Mil) to Dec. 2022 (kr164.67 Mil) but then declined from Dec. 2022 (kr164.67 Mil) to Dec. 2023 (kr99.89 Mil).


Cell Impact Cash And Cash Equivalents Historical Data

The historical data trend for Cell Impact's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cell Impact Cash And Cash Equivalents Chart

Cell Impact Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash And Cash Equivalents
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.91 151.93 28.56 164.67 99.89

Cell Impact Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 117.68 79.46 35.09 99.89 47.62

Cell Impact Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


Cell Impact  (OSTO:CI) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


Cell Impact Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Cell Impact's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


Cell Impact (OSTO:CI) Business Description

Traded in Other Exchanges
Address
Kallmossvagen 7A, Karlskoga, SWE, 691 52
Cell Impact develops technologies to produce flow plates for fuel cells. It provides graphite, stainless steel, and titanium flow plates. The company has developed and patented a unique method for high-velocity forming, Cell Impact Forming that makes it possible to produce flow plates with more advanced designs, which in turn creates more cost and energy-efficient fuel cells compared to conventional molding methods.

Cell Impact (OSTO:CI) Headlines

From GuruFocus

Q4 2021 Cigna Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2022 Cigna Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Cigna Corp at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 01-22-2024

Q2 2023 Cigna Group Earnings Call Transcript

By GuruFocus Research 01-22-2024

Cigna Corp Investor Day Transcript

By GuruFocus Research 01-22-2024

Cigna Corp at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 01-22-2024